Virginia’s Second Medical Cannabis Processor is Open to Patients

弗吉尼亚州第二家医用大麻加工厂向患者开放

2020-12-02 00:10:00 Business Times

本文共1043个字,阅读需3分钟

In late November, Detroit City Council formally approved a plan to allow adult-use cannabis sales within the city. Until then, the largest city in Michigan had joined the 1,400 or so municipalities that had opted out of an adult-use cannabis market approved by voters in 2018. The new ordinance will give licensing priority to longtime residents who have lived in Detroit for 15,13 or 10 of the past 30 years (with other qualifying factors, such as living in a low-income household or holding a past cannabis conviction), according to the Detroit Free Press. Those residents will have the first crack at half of the 75 retail licenses. Councilman James Tate has been out in front of this cause for the past year, insisting that a legal cannabis market represents an opportunity to broaden the scope of social equity in the city’s commercial landscape. "This is an industry that is in its infancy in Detroit, and we have to make sure that we nurture it properly and make sure that it grows strong, not reckless, and is a bridge to generational wealth that has been out of reach for so many families in our city," he said in October. Since the first day of adult-use sales, on Dec. 1, 2019, one year ago today, Michigan has recorded $439 million in cannabis sales (and $73 million in tax revenue).  CanBreed, an Israeli cannabis genetics seed company, announced this week its acquisition of a 3.5-acre hemp farm in San Diego. The company is part of the Smart-Agro R&D Partnership, a publicly traded firm on the Tel Aviv Stock Exchange. Construction of new facilities and greenhouses on the San Diego site is expected to begin early in the new year, with CanBreed selling stable genetics into the market by the end of 2021. Initial output, according to the company, is estimated at 12.5 million seeds annually. CanBreed’s goal runs up to 50 million seeds annually. In September, CanBreed secured a licensing agreement for foundational CRISPR-Cas9 patents held by Corteva Biosciences (MIT) and Broad Institute (Harvard) allowing the company to selectively edit its cannabis plants’ genetic material. In November, the company announced that its genome editing research had led it to a powdery mildew-resistant chemotype. “We want to be world leaders in using CRISPR technology for cannabis,” CERO Ido Margalit told the Times of Israel after signing the CRISPR-Cas9 agreement. “The idea is to sell stable enhanced cannabis seeds to the entire global market.” Two years ago, the European Union declared that CRISPR-edited crops are deemed genetically modified organisms (GMOs), making them illegal to sell. In the U.S., however, shortly after the EU decision, the federal government stepped aside to allow for more product innovation in the agricultural space.   “While these crops do not require regulatory oversight, we do have an important role to play in protecting plant health by evaluating products developed using modern biotechnology,” U.S. Agriculture Secretary Sonny Perdue said at the time.  
11月底,底特律市议会正式批准了一项允许在市内销售成人大麻的计划。在此之前,密歇根州最大的城市已经加入了1400多个城市的行列,这些城市在2018年获得选民的批准,选择退出成人大麻市场。 据《底特律自由报》报道,新的法令将给予在过去30年中在底特律居住了15年,13年或10年的长期居民优先发放许可证(还有其他资格因素,如居住在低收入家庭或有大麻犯罪记录)。这些居民将首先获得75张零售许可证中的一半。 在过去的一年里,议员詹姆斯·泰特一直站在这一事业的前面,他坚持认为,合法的大麻市场代表着一个机会,可以在城市的商业版图中扩大社会公平的范围。 “这是一个在底特律还处于起步阶段的产业,我们必须确保我们适当地培育它,确保它发展壮大,而不是鲁莽,并成为通往代际财富的桥梁,而代际财富对于我们城市的许多家庭来说是遥不可及的,”他在去年10月表示。 自2019年12月1日,也就是一年前的今天,开始销售成人大麻以来,密歇根州的大麻销售额已达到4.39亿美元(税收7300万美元)。 以色列大麻遗传种子公司CanBreed本周宣布收购位于圣地亚哥的3.5英亩大麻农场。该公司是Smart-Agro R&D Partnership的一部分,该公司是特拉维夫证券交易所的上市公司。 新设施和温室在圣地亚哥的建设预计将在新年早些时候开始,CanBreed将在2021年底向市场销售稳定的基因。据该公司称,初步产量估计为每年1250万粒种子。Canbreed的目标是每年生产5000万粒种子。 9月,CanBreed获得了Corteva Biosciences(MIT)和Broad Institute(Harvard)持有的CRISPR-Cas9基础专利的许可协议,允许该公司有选择地编辑其大麻植物的遗传物质。11月,该公司宣布其基因组编辑研究使其获得了抗白粉病的化学类型。 CERO Ido Margalit在签署CRISPR-Cas9协议后对《以色列时报》说:“我们希望成为使用CRISPR技术处理大麻的世界领导者。”“这个想法是向整个全球市场销售稳定的增强型大麻籽。” 两年前,欧盟宣布CRISPR编辑的作物被视为转基因生物(GMOs),使其非法销售。然而,在美国,在欧盟做出决定后不久,联邦政府就放弃了这一政策,允许在农业领域进行更多的产品创新。 美国农业部长桑尼·珀杜当时说:“虽然这些作物不需要监管,但我们通过评估利用现代生物技术开发的产品,在保护植物健康方面发挥着重要作用。”

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文